These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 12783603)
1. Current and potential pharmacological treatments for obsessive-compulsive disorder. Davidson J; Bjorgvinsson T Expert Opin Investig Drugs; 2003 Jun; 12(6):993-1001. PubMed ID: 12783603 [TBL] [Abstract][Full Text] [Related]
2. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. Berlin HA; Hamilton H; Hollander E Mt Sinai J Med; 2008; 75(3):174-203. PubMed ID: 18704978 [TBL] [Abstract][Full Text] [Related]
3. The future of pharmacotherapy for obsessive-compulsive disorder may lie in a better understanding of its heterogeneity. Brakoulias V Expert Opin Pharmacother; 2014 Jul; 15(10):1321-3. PubMed ID: 24866422 [TBL] [Abstract][Full Text] [Related]
4. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder. Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of fluoxetine on various subtypes of obsessive-compulsive disorder. Farnam A; Goreishizadeh MA; Farhang S Arch Iran Med; 2008 Sep; 11(5):522-5. PubMed ID: 18759519 [TBL] [Abstract][Full Text] [Related]